Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
HK Stock MarketDetailed Quotes
DINGDANG HEALTH (09886)
- 1.040
- 0.0000.00%
Trading May 7 13:23 CST
1.37BMarket Cap-25.37P/E (TTM)
1.050High1.020Low491.50KVolume1.030Open1.040Prev Close509.59KTurnover0.04%Turnover RatioLossP/E (Static)1.32BShares1.37052wk High0.74P/B1.37BFloat Cap0.34052wk Low--Dividend TTM1.32BShs Float20.200Historical High--Dividend LFY2.89%Range %0.305Historical Low1.037Avg Price500Lot Size--Div Yield TTM--Div Yield LFY
DINGDANG HEALTH (09886) Cash Flow
All
YOY
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 91.70%-30.72M | ---- | -67.30%-370.12M | ---- | 92.19%-221.23M | ---- | -79.04%-2.83B | ---- | 46.04%-402.09M | -75.59%-1.58B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 3.01%-27.86M | ---- | 11.96%-28.73M | ---- | -90.24%-32.63M | ---- | -311.79%-17.15M | ---- | -132.07%-2.27M | -17.69%-4.17M |
| Dividend (income)- adjustment | -4.87%-4.05M | ---- | -2.68%-3.86M | ---- | ---3.76M | ---- | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | -36.40%1.56M | ---- | --2.45M | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | -96.14%8M | ---- | 5,918.91%207.17M | ---- | 103.07%3.44M | ---- | 472.53%1.7M | ---- | 109.57%1.31M | -111.31%-455K |
| -Impairmen of inventory (reversal) | 1,387.09%7.08M | ---- | -117.82%-550K | ---- | 1,971.14%3.09M | ---- | 120.69%149K | ---- | 518.75%198K | -182.76%-720K |
| -Impairment of goodwill | ---- | ---- | --198.92M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | -89.52%923K | ---- | 2,373.03%8.8M | ---- | -76.97%356K | ---- | 483.40%1.55M | ---- | 87.56%1.12M | -91.60%265K |
| Revaluation surplus: | 66.12%-2.08M | ---- | 38.31%-6.14M | ---- | -100.40%-9.95M | ---- | 176.44%2.49B | ---- | -58.43%277.43M | 20.96%901.93M |
| -Other fair value changes | 66.12%-2.08M | ---- | 38.31%-6.14M | ---- | -100.40%-9.95M | ---- | 176.44%2.49B | ---- | -58.43%277.43M | 20.96%901.93M |
| Asset sale loss (gain): | -66.01%482K | ---- | 1,842.47%1.42M | ---- | 421.43%73K | ---- | -95.93%14K | ---- | -44,900.00%-448K | 132.86%344K |
| -Loss (gain) from sale of subsidiary company | -60.26%271K | ---- | --682K | ---- | ---- | ---- | ---- | ---- | ---- | 140.49%434K |
| -Loss (gain) on sale of property, machinery and equipment | -71.33%211K | ---- | 908.22%736K | ---- | 421.43%73K | ---- | 115.56%14K | ---- | -44,900.00%-448K | -460.00%-90K |
| Depreciation and amortization: | 1.73%140.71M | ---- | -1.20%138.32M | ---- | 3.47%140M | ---- | 0.02%135.31M | ---- | 9.82%33.05M | 80.68%135.29M |
| -Depreciation | -19.32%14M | ---- | -6.32%17.35M | ---- | -8.23%18.52M | ---- | -6.79%20.18M | ---- | -5.14%5.15M | 3.69%21.65M |
| -Amortization of intangible assets | -7.10%33.66M | ---- | -6.16%36.23M | ---- | 3.70%38.61M | ---- | 5.69%37.24M | ---- | 0.46%8.83M | 463.08%35.23M |
| Financial expense | 39.25%12.38M | ---- | 12.84%8.89M | ---- | -0.49%7.88M | ---- | -55.46%7.92M | ---- | -4.31%1.95M | 193.28%17.78M |
| Exchange Loss (gain) | 254.31%11.94M | ---- | -50.31%-7.74M | ---- | 64.19%-5.15M | ---- | -20.53%-14.37M | ---- | --6.5M | ---11.92M |
| Special items | -55.83%43.83M | ---- | -20.41%99.23M | ---- | -22.40%124.67M | ---- | -50.40%160.67M | ---- | 2,101.40%69.41M | 2,379.65%323.94M |
| Operating profit before the change of operating capital | 281.50%152.63M | ---- | 589.67%40.01M | ---- | 108.95%5.8M | ---- | 70.44%-64.78M | ---- | 64.70%-15.15M | -256.03%-219.13M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -300.73%-83.57M | ---- | 657.83%41.63M | ---- | 95.71%-7.46M | ---- | -58.49%-174.08M | ---- | -33.14%-85.15M | 5.29%-109.83M |
| Accounts receivable (increase)decrease | 104.11%1.01M | ---- | -125.51%-24.66M | ---- | 155.54%96.68M | ---- | -92.52%-174.06M | ---- | -64.44%-28.82M | -9.50%-90.41M |
| Accounts payable increase (decrease) | 203.57%95.31M | ---- | -1,295.36%-92.02M | ---- | -96.19%7.7M | ---- | 42.10%202.24M | ---- | 35.62%156.07M | 123.89%142.33M |
| Special items for working capital changes | -115.71%-6.41M | ---- | 144.55%40.81M | ---- | -1,444.31%-91.59M | ---- | -177.31%-5.93M | ---- | -147.18%-5.49M | -59.75%7.67M |
| Cash from business operations | 2,655.68%158.98M | 138.11%199.83M | -48.12%5.77M | -61.80%83.92M | 105.13%11.12M | 516.13%219.69M | 19.59%-216.61M | 216.12%35.66M | 286.47%21.48M | -51.80%-269.37M |
| Other taxs | -29.41%-22.16M | -30.83%-11.66M | -4.68%-17.12M | 7.06%-8.91M | 23.09%-16.36M | 27.10%-9.59M | 18.58%-21.27M | 9.82%-13.16M | -70.97%-8.6M | -67.54%-26.12M |
| Net cash from operations | 1,305.24%136.82M | 150.86%188.17M | -116.77%-11.35M | -64.30%75.01M | 97.80%-5.24M | 833.75%210.1M | 19.50%-237.87M | 149.68%22.5M | 177.80%12.88M | -53.07%-295.49M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -3.14%27.31M | -33.26%9.23M | -12.34%28.19M | -15.03%13.83M | 92.21%32.16M | 109.39%16.27M | 342.48%16.73M | 435.56%7.77M | 299.82%2.16M | 15.77%3.78M |
| Dividend received - investment | 4.87%4.05M | ---- | 2.68%3.86M | ---- | --3.76M | ---- | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%16K |
| Decrease in deposits (increase) | ---556.05M | -8,717.71%-432.16M | ---- | -105.49%-4.9M | 200.00%89.33M | --89.33M | ---89.33M | ---- | ---- | ---- |
| Sale of fixed assets | 174.87%1.09M | 64.44%148K | 17.75%398K | 592.31%90K | 199.12%338K | --13K | -65.02%113K | ---- | 3,990.91%450K | 243.62%323K |
| Purchase of fixed assets | -53.72%-26.33M | 12.56%-9.53M | -23.57%-17.13M | -154.85%-10.9M | 21.68%-13.86M | 60.39%-4.28M | 13.52%-17.7M | -27.17%-10.79M | -49.90%-5.76M | -4.45%-20.47M |
| Selling intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | -41.89%43K | ---- | ---- | 289.47%74K |
| Purchase of intangible assets | -16.84%-9.32M | -37.72%-4.06M | -18.69%-7.98M | 16.04%-2.95M | 45.30%-6.72M | 47.53%-3.51M | -38.89%-12.29M | -26.60%-6.69M | 56.42%-1.52M | -172.69%-8.85M |
| Sale of subsidiaries | 918.00%509K | --509K | --50K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | 67.67%2.08B | -27.73%486.98M | 7.96%1.24B | 12.28%673.81M | -81.75%1.15B | -84.18%600.09M | 52.33%6.3B | 104.70%3.79B | 46.78%1.65B | 23.84%4.14B |
| Cash on investment | -112.83%-2.32B | -30.36%-830.04M | 5.10%-1.09B | -5.74%-636.73M | 82.44%-1.15B | 84.10%-602.16M | -72.20%-6.55B | -139.42%-3.79B | -90.67%-1.69B | -5.48%-3.81B |
| Net cash from investment operations | -610.45%-801.19M | -2,515.64%-778.92M | 50.45%156.96M | -66.33%32.25M | 129.52%104.32M | 2,199.89%95.76M | -215.26%-353.42M | -101.76%-4.56M | -117.21%-40.26M | 163.03%306.64M |
| Net cash before financing | -556.28%-664.37M | -650.80%-590.75M | 46.95%145.61M | -64.93%107.25M | 116.76%99.09M | 1,604.79%305.86M | -5,405.40%-591.29M | -91.59%17.94M | -112.59%-27.39M | 101.64%11.15M |
| Cash flow from financing activities | ||||||||||
| New borrowing | --4.65M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4,312.17%1.27B |
| Refund | ---- | ---- | ---- | ---- | ---- | ---- | 99.98%-234K | 100.00%-20K | 99.99%-2K | -2,160,905.00%-1.3B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | -88.11%325.82M | ---- | ---- | 232.20%2.74B |
| Interest paid - financing | -39.25%-12.38M | -26.78%-5.52M | -12.84%-8.89M | -10.77%-4.35M | 0.49%-7.88M | -2.37%-3.93M | 55.46%-7.92M | 72.68%-3.84M | 4.31%-1.95M | -193.28%-17.78M |
| Dividends paid - financing | 52.65%-7.19M | ---- | -113.82%-15.18M | -26.10%-8.95M | 29.75%-7.1M | 25.64%-7.1M | -704.94%-10.1M | -715.03%-9.54M | ---- | 80.17%-1.26M |
| Absorb investment income | ---- | ---- | --749K | --1.05M | ---- | ---- | ---- | ---- | ---- | 262.24%3.55M |
| Issuance expenses and redemption of securities expenses | 24.16%-9.04M | ---- | -4,024.91%-11.92M | ---- | 63.51%-289K | 65.10%-289K | 99.94%-792K | 99.94%-828K | -84.40%-1.06M | -2,107,793.75%-1.35B |
| Other items of the financing business | 74.42%-1.53M | ---- | 81.98%-5.98M | ---10.93M | ---33.19M | ---- | ---- | ---- | ---- | ---2.8M |
| Net cash from financing operations | 7.66%-112.08M | 25.22%-46.83M | 7.02%-121.37M | -29.80%-62.62M | -156.05%-130.54M | 1.51%-48.24M | -81.68%232.9M | -103.72%-48.98M | 59.11%-20.88M | 59.86%1.27B |
| Effect of rate | -255.76%-12.18M | -234.61%-4.1M | 22.19%7.82M | -67.75%3.05M | -60.85%6.4M | 126.13%9.45M | 68.13%16.35M | -79.38%4.18M | ---6.5M | --9.72M |
| Net Cash | -3,303.58%-776.45M | -1,528.46%-637.58M | 177.07%24.24M | -82.67%44.63M | 91.22%-31.45M | 929.92%257.61M | -127.94%-358.39M | -102.03%-31.04M | -129.01%-48.27M | 1,006.89%1.28B |
| Begining period cash | 2.70%1.22B | 2.70%1.22B | -2.07%1.19B | -2.07%1.19B | -22.02%1.21B | -22.02%1.21B | 495.99%1.55B | 495.99%1.55B | 495.99%1.55B | 80.09%260.57M |
| Cash at the end | -64.75%429.32M | -53.28%576.27M | 2.70%1.22B | -16.54%1.23B | -2.07%1.19B | -3.15%1.48B | -22.02%1.21B | -15.70%1.53B | 250.91%1.5B | 495.99%1.55B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion |
| Auditor | -- | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | -- | Deloitte Touche Tohmatsu会计师事务所 |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"